15 Results for "

SARS-CoV-2 Mpro-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "SARS-CoV-2 Mpro-IN-1" in MCE Product Catalog:

Cat. No.: HY-144464
CAS No.: 2758359-91-8
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 Mpro-IN-1 (compound 16b-3) is a potent, selective and irreversible inhibitor of SARS-CoV-2 main protease (Mpro), with an IC50 of 116 nM [1].
loading...
    loading...
Cat. No.: HY-151990
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2/MERS Mpro-IN-1 (compound 9c) is a potent SARS-CoV-2 and MERS main protease inhibitor with IC50 values of 0.10, 0.06 µM, respectively [1].
loading...
    loading...
Cat. No.: HY-W004812
CAS No.: 161660-94-2
Synonyms: (1S,3S)-3-[(tert-Butoxycarbonyl)amINo]cyclopentanecarboxylic acid
Research Areas:  

Infection

BOC-(1R,3S)-3-aminocyclopentane carboxylic acid ((1S,3S)-3-[(tert-Butoxycarbonyl)amino]cyclopentanecarboxylic acid) is a conformationally constrained peptide building block and a key component of SARS-CoV-2 main protease (Mpro) inhibitors. When incorporated into macrocyclic peptides, BOC-(1R,3S)-3-aminocyclopentane carboxylic acid not only helps generate high-affinity Mpro inhibitors by preorganizing the secondary structure of peptides, but also exerts sequence-dependent functional inhibition on the hydrolytic activity of Mpro. BOC-(1R,3S)-3-aminocyclopentane carboxylic is widely used in COVID-19-related research [1].
loading...
    loading...
Cat. No.: HY-N12697A
CAS No.: 175669-29-1
Polycarpine hydrochloride (1a) is a broad-spectrum Mpro inhibitor (IC50 = 30 nM) that can be isolated from the Polycarpa aurata and also serves as an anti-coronaviral agent. Polycarpine hydrochloride possesses antiviral and antifungal activities, with IC50 values of 30.0 nM and 0.12 μM against SARS-CoV-2 Mpro and PEDV Mpro, respectively .
loading...
    loading...
Cat. No.: HY-136606
CAS No.: 2413716-71-7
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV MPro-IN-1 is a SARS-CoV-2 3CLpro covalent inhibitor, with an IC50 of 40 nM. SARS-CoV MPro-IN-1 shows good anti-SARS-CoV-2-infection activity in cell culture with an EC50 of 0.33 μM. SARS-CoV MPro-IN-1 has the potential for COVID-19 research [1].
loading...
    loading...
Cat. No.: HY-157804
CAS No.: 3029579-46-9
Research Areas:  

Infection

PROTAC SARS-CoV-2 Mpro degrader-1 is a SARS-CoV-2 M pro PROTAC degrader with a DC50 of 18.1 μM. PROTAC SARS-CoV-2 Mpro degrader-1 recruits the Von-Hippel Lindau (VHL) E3 ligase to mediate ubiquitination and proteasomal degradation of SARS-CoV-2 M pro, without inhibiting the catalytic activity of M pro. PROTAC SARS-CoV-2 Mpro degrader-1 exhibits broad-spectrum antiviral activity against coronaviruses (SARS-CoV-2, HCoV-OC43, HCoV-229E). PROTAC SARS-CoV-2 Mpro degrader-1 can be used in studies related to SARS-CoV-2 infection, HCoV-OC43 infection, and HCoV-229E infection [1].
loading...
    loading...
Cat. No.: HY-169260
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 Mpro-IN-27 (Compound 4h) is a potent SARS-CoV-2 Mpro inhibitor .
loading...
    loading...
Cat. No.: HY-176442
SARS-CoV-2 Mpro ligand 1 (Compound S15) is a PROTAC target protein ligand. SARS-CoV-2 Mpro ligand 1 can be used to synthesize BP-198 (HY-176440) [1].
loading...
    loading...
Cat. No.: HY-178772
CAS No.: 3038701-72-0
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 Mpro-IN-50 (Compound 30) is a noncovalent SARS-CoV-2 Mpro inhibitor with an IC50 of 14  nM. SARS-CoV-2 Mpro-IN-50 is also a pan-CoV Mpro inhibitor with IC50 s of 20-190 nM for SARS-CoV-1 Mpro, 229E Mpro, HKU1 Mpro, MERS Mpro, NL63 Mpro and OC43 Mpro. SARS-CoV-2 Mpro-IN-50 has significant antiviral activity against the SARS-CoV-2 omicron variant (EC50 : 22  nM). SARS-CoV-2 Mpro-IN-50 can be used for coronavirus infections research [1].
loading...
    loading...
Cat. No.: HY-161790
Mpro ligand 1 is the ligand for target protein for PROTAC SARS-CoV-2 Mpro degrader-3 (HY-161789). Mpro ligand 1 is the active form of Mpro ligand 2 (HY-161791) [1].
loading...
    loading...
Cat. No.: HY-155144
CAS No.: 2894104-50-6
Purity:  99.60%
Target:  

SARS-CoV

Research Areas:  

Infection

CDD-1845 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 3 nM. CDD-1845 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants .
loading...
    loading...
Cat. No.: HY-155142
CAS No.: 2894104-40-4
Target:  

SARS-CoV

Research Areas:  

Infection

CDD-1819 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 5 nM. CDD-1819 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants .
loading...
    loading...
Cat. No.: HY-155143
CAS No.: 2894104-33-5
Target:  

SARS-CoV

Research Areas:  

Infection

CDD-1733 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 12 nM. CDD-1733 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants .
loading...
    loading...
Cat. No.: HY-176441
CAS No.: 2416133-92-9
Target:  

Ligands for E3 Ligase

Research Areas:  

Infection

E3 ligase Ligand 66 is an E3 ligase ligand that can be used to recruit IAP proteins. E3 ligase Ligand 66 can be linked to SARS-CoV-2 Mpro ligand 1 (HY-176442) through a linker to form PROTAC BP-198 (HY-176440) [1].
loading...
    loading...
Cat. No.: HY-178374
Target:  

Beta-secretase SARS-CoV

Research Areas:  

Infection Neurological Disease

BACE-1/Mpro-IN-1 is a high brain-penetrant BACE-1 (IC50 = 0.26 μM) and SARS-CoV-2 Mpro (IC50 = 0.91 μM) dual inhibitor. BACE-1/Mpro-IN-1 binds to the aspartyl protease and cysteine protease as a mixed-type inhibitor. BACE-1/Mpro-IN-1 exhibits the most favorable docking score and a strong interaction profile. BACE-1/Mpro-IN-1 can be used for the study of COVID-19 exacerbated Neuroinflammation and Alzheimer’s disease [1].
loading...
    loading...
  • 1